Publications of the Plückthun Group
ZORA Publication List
Download Options
Publications
-
2021
-
Generation of ordered protein assemblies using rigid three-body fusion Proceedings of the National Academy of Sciences of the United States of America, 118, e2015037118. https://doi.org/10.1073/pnas.2015037118
-
The SHREAD gene therapy platform for paracrine delivery improves tumor localization and intratumoral effects of a clinical antibody Proceedings of the National Academy of Sciences of the United States of America, 118, e2017925118. https://doi.org/10.1073/pnas.2017925118
-
An Approach for the Real-Time Quantification of Cytosolic Protein-Protein Interactions in Living Cells ACS Sensors, 6, 1572–1582. https://doi.org/10.1021/acssensors.0c02480
-
Directed evolution for high functional production and stability of a challenging G protein-coupled receptor Scientific Reports, 11, 8630. https://doi.org/10.1038/s41598-021-87793-9
-
Engineering of Challenging G Protein-Coupled Receptors for Structure Determination and Biophysical Studies Molecules, 26, 1465. https://doi.org/10.3390/molecules26051465
-
iMATCH: an integrated modular assembly system for therapeutic combination high-capacity adenovirus gene therapy Molecular Therapy - Methods & Clinical Development, 20, 572–586. https://doi.org/10.1016/j.omtm.2021.01.002
-
Cryo-EM structure of an activated GPCR-G protein complex in lipid nanodiscs Nature Structural & Molecular Biology, 28, 258–267. https://doi.org/10.1038/s41594-020-00554-6
-
Probing the Conformation States of Neurotensin Receptor 1 Variants by NMR Site-Directed Methyl Labeling Chembiochem, 22, 139–146. https://doi.org/10.1002/cbic.202000541
-
Flavonol-mediated stabilization of PIN efflux complexes regulates polar auxin transport The EMBO Journal, 40, e104416. https://doi.org/10.15252/embj.2020104416
-
Complexes of the neurotensin receptor 1 with small-molecule ligands reveal structural determinants of full, partial, and inverse agonism Science Advances, 7, eabe5504. https://doi.org/10.1126/sciadv.abe5504
-
-
2020
-
Optimizing the anti-tumor efficacy of protein-drug conjugates by engineering the molecular size and half-life Journal of Controlled Release, 327, 186–197. https://doi.org/10.1016/j.jconrel.2020.08.004
-
Animal-free alternatives and the antibody iceberg Nature Biotechnology, 38, 1234–1239. https://doi.org/10.1038/s41587-020-0687-9
-
Engineering Af1521 improves ADP-ribose binding and identification of ADP-ribosylated proteins Nature Communications, 11, 5199. https://doi.org/10.1038/s41467-020-18981-w
-
Optimizing the α1B-adrenergic receptor for solution NMR studies Biochimica et Biophysica Acta. Biomembranes, 1862, 183354. https://doi.org/10.1016/j.bbamem.2020.183354
-
Reengineering anthrax toxin protective antigen for improved receptor-specific protein delivery BMC Biology, 18, 100. https://doi.org/10.1186/s12915-020-00827-y
-
Animal-derived-antibody generation faces strict reform in accordance with European Union policy on animal use Nature Methods, 17, 755–756. https://doi.org/10.1038/s41592-020-0906-9
-
Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness MAbs, 12, 1792084. https://doi.org/10.1080/19420862.2020.1792084
-
Salmonella-based platform for efficient delivery of functional binding proteins to the cytosol Communications Biology, 3, 342. https://doi.org/10.1038/s42003-020-1072-4
-
Crystal structure of the human oxytocin receptor Science Advances, 6, eabb5419. https://doi.org/10.1126/sciadv.abb5419
-
Lactoferrin-hexon interactions mediate CAR-independent adenovirus infection of human respiratory cells Journal of Virology, 94, e00542-20. https://doi.org/10.1128/JVI.00542-20
-